comparemela.com

Latest Breaking News On - Susquehanna fundamental investments - Page 11 : comparemela.com

Jumia Technologies (NYSE:JMIA) Shares Up 7.1%

Jumia Technologies AG (NYSE:JMIA – Get Free Report) traded up 7.1% during mid-day trading on Wednesday . The stock traded as high as $6.51 and last traded at $6.50. 2,925,615 shares traded hands during mid-day trading, a decline of 2% from the average session volume of 2,999,267 shares. The stock had previously closed at $6.07. […]

United-arab-emirates
South-africa
Blair-william-co
Global-retirement-partners
Deuterium-capital-management
Capstone-investment-advisors
Jumia-technologies-company-profile
Susquehanna-fundamental-investments
Jumia-technologies
Get-free-report
Fundamental-investments

Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Price Target at $6.42

Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have earned an average rating of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price […]

Seana-mccarthy
Sg-americas-securities
Cytomx-therapeutics-inc
Jpmorgan-chase-co
Susquehanna-fundamental-investments
Nasdaq
Congress-park-capital
Acadian-asset-management
Alphamark-advisors
Cytomx-therapeutics
Get-free-report

Grindr Inc. (NYSE:GRND) Director James Fu Bin Lu Sells 1,000,000 Shares

Grindr Inc. (NYSE:GRND – Get Free Report) Director James Fu Bin Lu sold 1,000,000 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $10.00, for a total value of $10,000,000.00. Following the completion of the transaction, the director now owns 37,708,301 shares of […]

New-york
United-states
Raymond-james
Pricet-rowe-associates-inc
Susquehanna-fundamental-investments
Grindr-company-profile
Jump-financial
Grindr-inc
York-state-common-retirement-fund
Capital-partners
Get-free-report
Trading-down

Caribou Biosciences (NASDAQ:CRBU) Given "Buy" Rating at Truist Financial

Caribou Biosciences (NASDAQ:CRBU – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Truist Financial in a research note issued to investors on Thursday, Benzinga reports. They presently have a $19.00 target price on the stock. Truist Financial’s target price indicates a potential upside of 426.32% from the stock’s current price. […]

United-states
Caribou-biosciences-company-profile
Susquehanna-fundamental-investments
Vanguard-group-inc
Acadian-asset-management
Caribou-biosciences-inc
Caribou-biosciences
Get-free-report
Truist-financial
Capital-management
Asset-management

Pixelworks (NASDAQ:PXLW) Price Target Lowered to $2.00 at Roth Mkm

Pixelworks (NASDAQ:PXLW – Free Report) had its target price decreased by Roth Mkm from $3.00 to $2.00 in a research note published on Wednesday, Benzinga reports. Roth Mkm currently has a buy rating on the semiconductor company’s stock. Other equities analysts have also recently issued research reports about the stock. StockNews.com cut shares of Pixelworks […]

Japan
China
United-states
Taiwan
Roth-mkm
Essex-investment-management-co
Connor-clark-lunn-investment-management-ltd
Pixelworks-inc
Susquehanna-fundamental-investments
Traynor-capital-management-inc
Needham-company
Sg-americas-securities

vimarsana © 2020. All Rights Reserved.